The Rise of HPAPI Molecules - Trends in Highly Potent API Manufacturing

Content Type: Whitepaper/Executive Summary

Authors: Maurits Janssen

Publish Date: 9/16/2020

Highly potent active pharmaceutical ingredients are increasing in pharma pipelines.  Lonza offers all HPAPI-related expertise to support your product development from concept to commercial use in an integrated manner. To learn more, read our whitepaper.